Reklama
powiązane z: anti-myelin oligodendrocyte glycoproteinDevelopment and manufacturing of raw materials, APIs and intermediates from 1kg to 1,000kg. 22 fermentation lines to support formulation development.
Search results
MOG (myelin oligodendrocyte glycoprotein) antibody disease (MOGAD) or MOG antibody-associated encephalomyelitis (MOG-EM) [1] is an inflammatory demyelinating disease of the central nervous system.
3 sty 2024 · Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In MOGAD, the immune system attacks the fatty substance that protects nerve fibers in the optic nerves, brain and spinal cord.
Myelin oligodendrocyte glycoprotein (MOG) is a glycoprotein believed to be important in the myelination of nerves in the central nervous system (CNS). In humans this protein is encoded by the MOG gene.
22 lip 2024 · Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder of the central nervous system characterized by attacks of immune-mediated demyelination predominantly targeting the optic nerves, brain, and spinal cord. The disease has a predilection for children.
13 wrz 2024 · The concepts of neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are evolving, with increasing recognition of the...
Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. Although no age group is exempt, median age of onset is within the fourth decade of life, with optic neuritis being the most frequent presenting phenotype.
14 maj 2020 · Antibodies against myelin oligodendrocyte glycoprotein (MOG-Ab) have been found in some cases of these demyelinating diseases, particularly in children.
Reklama
powiązane z: anti-myelin oligodendrocyte glycoproteinDevelopment and manufacturing of raw materials, APIs and intermediates from 1kg to 1,000kg. 22 fermentation lines to support formulation development.
